Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development

Glutathione-S transferases (GSTs) are xenobiotic-conjugation enzymes involved in the detoxification process of heterocyclic aromatic amines and polycyclic aromatic hydrocarbons, widely recognized risk factors of colorectal cancer (CRC) development. Polymorphism in GSTs often leads to alteration or c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pathology oncology research 2019-10, Vol.25 (4), p.1579-1587
Hauptverfasser: Stojkovic Lalosevic, Milica Lj, Coric, Vesna M., Pekmezovic, Tatjana D., Simic, Tatjana P., Pljesa Ercegovac, Marija S., Pavlovic Markovic, Aleksandra R., Krivokapic, Zoran V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1587
container_issue 4
container_start_page 1579
container_title Pathology oncology research
container_volume 25
creator Stojkovic Lalosevic, Milica Lj
Coric, Vesna M.
Pekmezovic, Tatjana D.
Simic, Tatjana P.
Pljesa Ercegovac, Marija S.
Pavlovic Markovic, Aleksandra R.
Krivokapic, Zoran V.
description Glutathione-S transferases (GSTs) are xenobiotic-conjugation enzymes involved in the detoxification process of heterocyclic aromatic amines and polycyclic aromatic hydrocarbons, widely recognized risk factors of colorectal cancer (CRC) development. Polymorphism in GSTs often leads to alteration or complete lack of enzyme activity, which might have an effect on CRC carcinogenesis. Aim of this study was to investigate GST gene variants as risk factors in patients with CRC. A total of 523 CRC patients administered for surgical resection and 400 matched controls were included. Deletion polymorphism of GSTs M1 and T1 was investigated by polymerase chain reaction. Single nucleotide polymorphism of GST A1 and P1 was investigated by restriction fragment length polymorphism method. The association between GST genotype and risk of CRC development was found in carriers of GSTT1-null and GSTP1-variant genotypes individually ( p  = 0.050 and p  = 0.016, respectively). Furthermore, statistically significant association was found when combination of GSTP1-variant genotype with any of other three common GST genotypes was analyzed with respect to CRC susceptibility. Additionally, patients with combined GSTM1-null/GSTT1-null/GSTA1 low-activity/GSTP1-variant genotype showed 2.71-fold increased risk of developing CRC ( p  = 0.037). This study supports hypothesis that GST polymorphisms might have an important role in the process of the CRC development. Additionally, GSTM1-null/ GSTT1-null/ GSTA1 low-activity/ GSTP1-variant genotype could be combination of GST genotypes whose carriers are more prone to CRC development.
doi_str_mv 10.1007/s12253-019-00589-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2308968268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2172483765</sourcerecordid><originalsourceid>FETCH-LOGICAL-c403t-84a85beace26383a4c7b7afb73cf02884cb9d0f9e57b2fb91f349270df546e003</originalsourceid><addsrcrecordid>eNp9kbtuFTEURUcIRB7wAxTIEvUEvx8luoGAFAFSQm15PMfJRB77YnuQUvDvGG6ALpWPddbep1jD8IrgM4KxelsJpYKNmJgRY6HNSJ4Mx0QwOlKN1dM-077iRsij4aTWO9xD0sjnwxHD0nBB9PHw8xwitCUn5NKMrpZ0EwF93nyE3JYZ0Ncc79dc9rdLXStaEtrlde30Rdyaa7c9COMVui4u1QDFVaidSK0s09YAtdx_MRfwzUW0c8lDQefwA2Ler5Dai-FZcLHCy4f3dPj24f317uN4-eXi0-7d5eg5Zm3U3GkxgfNAJdPMca8m5cKkmA-Yas39ZGYcDAg10TAZEhg3VOE5CC4BY3Y6vDn07kv-vkFt9i5vJfWTljKsjdRU6kcpoijXTEnRKXqgfMm1Fgh2X5bVlXtLsP3txR682O7F_vFiSQ-9fqjephXmf5G_IjrADkDtq3QD5f_tR2p_AVEGmd4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2172483765</pqid></control><display><type>article</type><title>Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Stojkovic Lalosevic, Milica Lj ; Coric, Vesna M. ; Pekmezovic, Tatjana D. ; Simic, Tatjana P. ; Pljesa Ercegovac, Marija S. ; Pavlovic Markovic, Aleksandra R. ; Krivokapic, Zoran V.</creator><creatorcontrib>Stojkovic Lalosevic, Milica Lj ; Coric, Vesna M. ; Pekmezovic, Tatjana D. ; Simic, Tatjana P. ; Pljesa Ercegovac, Marija S. ; Pavlovic Markovic, Aleksandra R. ; Krivokapic, Zoran V.</creatorcontrib><description>Glutathione-S transferases (GSTs) are xenobiotic-conjugation enzymes involved in the detoxification process of heterocyclic aromatic amines and polycyclic aromatic hydrocarbons, widely recognized risk factors of colorectal cancer (CRC) development. Polymorphism in GSTs often leads to alteration or complete lack of enzyme activity, which might have an effect on CRC carcinogenesis. Aim of this study was to investigate GST gene variants as risk factors in patients with CRC. A total of 523 CRC patients administered for surgical resection and 400 matched controls were included. Deletion polymorphism of GSTs M1 and T1 was investigated by polymerase chain reaction. Single nucleotide polymorphism of GST A1 and P1 was investigated by restriction fragment length polymorphism method. The association between GST genotype and risk of CRC development was found in carriers of GSTT1-null and GSTP1-variant genotypes individually ( p  = 0.050 and p  = 0.016, respectively). Furthermore, statistically significant association was found when combination of GSTP1-variant genotype with any of other three common GST genotypes was analyzed with respect to CRC susceptibility. Additionally, patients with combined GSTM1-null/GSTT1-null/GSTA1 low-activity/GSTP1-variant genotype showed 2.71-fold increased risk of developing CRC ( p  = 0.037). This study supports hypothesis that GST polymorphisms might have an important role in the process of the CRC development. Additionally, GSTM1-null/ GSTT1-null/ GSTA1 low-activity/ GSTP1-variant genotype could be combination of GST genotypes whose carriers are more prone to CRC development.</description><identifier>ISSN: 1219-4956</identifier><identifier>EISSN: 1532-2807</identifier><identifier>DOI: 10.1007/s12253-019-00589-1</identifier><identifier>PMID: 30694518</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Amines ; Biomarkers, Tumor - genetics ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Carcinogenesis ; Case-Control Studies ; Clonal deletion ; Colorectal cancer ; Colorectal carcinoma ; Colorectal Neoplasms - genetics ; Colorectal Neoplasms - pathology ; Detoxification ; Enzymatic activity ; Female ; Follow-Up Studies ; Gene deletion ; Gene polymorphism ; Genetic Predisposition to Disease ; Genotype ; Genotype &amp; phenotype ; Genotypes ; Glutathione ; Glutathione S-Transferase pi - genetics ; Glutathione transferase ; Glutathione Transferase - genetics ; GSTM1 protein ; GSTT1 protein ; Health risks ; Humans ; Immunology ; Male ; Middle Aged ; Oncology ; Original Article ; Pathology ; Polycyclic aromatic hydrocarbons ; Polymerase chain reaction ; Polymorphism ; Polymorphism, Single Nucleotide ; Prognosis ; Restriction fragment length polymorphism ; Risk Factors ; Sequence Deletion ; Single-nucleotide polymorphism ; Statistical analysis</subject><ispartof>Pathology oncology research, 2019-10, Vol.25 (4), p.1579-1587</ispartof><rights>Arányi Lajos Foundation 2019</rights><rights>Pathology &amp; Oncology Research is a copyright of Springer, (2019). All Rights Reserved.</rights><rights>Copyright Springer Nature B.V. 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c403t-84a85beace26383a4c7b7afb73cf02884cb9d0f9e57b2fb91f349270df546e003</citedby><cites>FETCH-LOGICAL-c403t-84a85beace26383a4c7b7afb73cf02884cb9d0f9e57b2fb91f349270df546e003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12253-019-00589-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12253-019-00589-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,782,786,27931,27932,41495,42564,51326</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30694518$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stojkovic Lalosevic, Milica Lj</creatorcontrib><creatorcontrib>Coric, Vesna M.</creatorcontrib><creatorcontrib>Pekmezovic, Tatjana D.</creatorcontrib><creatorcontrib>Simic, Tatjana P.</creatorcontrib><creatorcontrib>Pljesa Ercegovac, Marija S.</creatorcontrib><creatorcontrib>Pavlovic Markovic, Aleksandra R.</creatorcontrib><creatorcontrib>Krivokapic, Zoran V.</creatorcontrib><title>Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development</title><title>Pathology oncology research</title><addtitle>Pathol. Oncol. Res</addtitle><addtitle>Pathol Oncol Res</addtitle><description>Glutathione-S transferases (GSTs) are xenobiotic-conjugation enzymes involved in the detoxification process of heterocyclic aromatic amines and polycyclic aromatic hydrocarbons, widely recognized risk factors of colorectal cancer (CRC) development. Polymorphism in GSTs often leads to alteration or complete lack of enzyme activity, which might have an effect on CRC carcinogenesis. Aim of this study was to investigate GST gene variants as risk factors in patients with CRC. A total of 523 CRC patients administered for surgical resection and 400 matched controls were included. Deletion polymorphism of GSTs M1 and T1 was investigated by polymerase chain reaction. Single nucleotide polymorphism of GST A1 and P1 was investigated by restriction fragment length polymorphism method. The association between GST genotype and risk of CRC development was found in carriers of GSTT1-null and GSTP1-variant genotypes individually ( p  = 0.050 and p  = 0.016, respectively). Furthermore, statistically significant association was found when combination of GSTP1-variant genotype with any of other three common GST genotypes was analyzed with respect to CRC susceptibility. Additionally, patients with combined GSTM1-null/GSTT1-null/GSTA1 low-activity/GSTP1-variant genotype showed 2.71-fold increased risk of developing CRC ( p  = 0.037). This study supports hypothesis that GST polymorphisms might have an important role in the process of the CRC development. Additionally, GSTM1-null/ GSTT1-null/ GSTA1 low-activity/ GSTP1-variant genotype could be combination of GST genotypes whose carriers are more prone to CRC development.</description><subject>Amines</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Carcinogenesis</subject><subject>Case-Control Studies</subject><subject>Clonal deletion</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Detoxification</subject><subject>Enzymatic activity</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Gene deletion</subject><subject>Gene polymorphism</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>Genotype &amp; phenotype</subject><subject>Genotypes</subject><subject>Glutathione</subject><subject>Glutathione S-Transferase pi - genetics</subject><subject>Glutathione transferase</subject><subject>Glutathione Transferase - genetics</subject><subject>GSTM1 protein</subject><subject>GSTT1 protein</subject><subject>Health risks</subject><subject>Humans</subject><subject>Immunology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Pathology</subject><subject>Polycyclic aromatic hydrocarbons</subject><subject>Polymerase chain reaction</subject><subject>Polymorphism</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Prognosis</subject><subject>Restriction fragment length polymorphism</subject><subject>Risk Factors</subject><subject>Sequence Deletion</subject><subject>Single-nucleotide polymorphism</subject><subject>Statistical analysis</subject><issn>1219-4956</issn><issn>1532-2807</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kbtuFTEURUcIRB7wAxTIEvUEvx8luoGAFAFSQm15PMfJRB77YnuQUvDvGG6ALpWPddbep1jD8IrgM4KxelsJpYKNmJgRY6HNSJ4Mx0QwOlKN1dM-077iRsij4aTWO9xD0sjnwxHD0nBB9PHw8xwitCUn5NKMrpZ0EwF93nyE3JYZ0Ncc79dc9rdLXStaEtrlde30Rdyaa7c9COMVui4u1QDFVaidSK0s09YAtdx_MRfwzUW0c8lDQefwA2Ler5Dai-FZcLHCy4f3dPj24f317uN4-eXi0-7d5eg5Zm3U3GkxgfNAJdPMca8m5cKkmA-Yas39ZGYcDAg10TAZEhg3VOE5CC4BY3Y6vDn07kv-vkFt9i5vJfWTljKsjdRU6kcpoijXTEnRKXqgfMm1Fgh2X5bVlXtLsP3txR682O7F_vFiSQ-9fqjephXmf5G_IjrADkDtq3QD5f_tR2p_AVEGmd4</recordid><startdate>20191001</startdate><enddate>20191001</enddate><creator>Stojkovic Lalosevic, Milica Lj</creator><creator>Coric, Vesna M.</creator><creator>Pekmezovic, Tatjana D.</creator><creator>Simic, Tatjana P.</creator><creator>Pljesa Ercegovac, Marija S.</creator><creator>Pavlovic Markovic, Aleksandra R.</creator><creator>Krivokapic, Zoran V.</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20191001</creationdate><title>Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development</title><author>Stojkovic Lalosevic, Milica Lj ; Coric, Vesna M. ; Pekmezovic, Tatjana D. ; Simic, Tatjana P. ; Pljesa Ercegovac, Marija S. ; Pavlovic Markovic, Aleksandra R. ; Krivokapic, Zoran V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c403t-84a85beace26383a4c7b7afb73cf02884cb9d0f9e57b2fb91f349270df546e003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Amines</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Carcinogenesis</topic><topic>Case-Control Studies</topic><topic>Clonal deletion</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Detoxification</topic><topic>Enzymatic activity</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Gene deletion</topic><topic>Gene polymorphism</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>Genotype &amp; phenotype</topic><topic>Genotypes</topic><topic>Glutathione</topic><topic>Glutathione S-Transferase pi - genetics</topic><topic>Glutathione transferase</topic><topic>Glutathione Transferase - genetics</topic><topic>GSTM1 protein</topic><topic>GSTT1 protein</topic><topic>Health risks</topic><topic>Humans</topic><topic>Immunology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Pathology</topic><topic>Polycyclic aromatic hydrocarbons</topic><topic>Polymerase chain reaction</topic><topic>Polymorphism</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Prognosis</topic><topic>Restriction fragment length polymorphism</topic><topic>Risk Factors</topic><topic>Sequence Deletion</topic><topic>Single-nucleotide polymorphism</topic><topic>Statistical analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stojkovic Lalosevic, Milica Lj</creatorcontrib><creatorcontrib>Coric, Vesna M.</creatorcontrib><creatorcontrib>Pekmezovic, Tatjana D.</creatorcontrib><creatorcontrib>Simic, Tatjana P.</creatorcontrib><creatorcontrib>Pljesa Ercegovac, Marija S.</creatorcontrib><creatorcontrib>Pavlovic Markovic, Aleksandra R.</creatorcontrib><creatorcontrib>Krivokapic, Zoran V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Pathology oncology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stojkovic Lalosevic, Milica Lj</au><au>Coric, Vesna M.</au><au>Pekmezovic, Tatjana D.</au><au>Simic, Tatjana P.</au><au>Pljesa Ercegovac, Marija S.</au><au>Pavlovic Markovic, Aleksandra R.</au><au>Krivokapic, Zoran V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development</atitle><jtitle>Pathology oncology research</jtitle><stitle>Pathol. Oncol. Res</stitle><addtitle>Pathol Oncol Res</addtitle><date>2019-10-01</date><risdate>2019</risdate><volume>25</volume><issue>4</issue><spage>1579</spage><epage>1587</epage><pages>1579-1587</pages><issn>1219-4956</issn><eissn>1532-2807</eissn><abstract>Glutathione-S transferases (GSTs) are xenobiotic-conjugation enzymes involved in the detoxification process of heterocyclic aromatic amines and polycyclic aromatic hydrocarbons, widely recognized risk factors of colorectal cancer (CRC) development. Polymorphism in GSTs often leads to alteration or complete lack of enzyme activity, which might have an effect on CRC carcinogenesis. Aim of this study was to investigate GST gene variants as risk factors in patients with CRC. A total of 523 CRC patients administered for surgical resection and 400 matched controls were included. Deletion polymorphism of GSTs M1 and T1 was investigated by polymerase chain reaction. Single nucleotide polymorphism of GST A1 and P1 was investigated by restriction fragment length polymorphism method. The association between GST genotype and risk of CRC development was found in carriers of GSTT1-null and GSTP1-variant genotypes individually ( p  = 0.050 and p  = 0.016, respectively). Furthermore, statistically significant association was found when combination of GSTP1-variant genotype with any of other three common GST genotypes was analyzed with respect to CRC susceptibility. Additionally, patients with combined GSTM1-null/GSTT1-null/GSTA1 low-activity/GSTP1-variant genotype showed 2.71-fold increased risk of developing CRC ( p  = 0.037). This study supports hypothesis that GST polymorphisms might have an important role in the process of the CRC development. Additionally, GSTM1-null/ GSTT1-null/ GSTA1 low-activity/ GSTP1-variant genotype could be combination of GST genotypes whose carriers are more prone to CRC development.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>30694518</pmid><doi>10.1007/s12253-019-00589-1</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1219-4956
ispartof Pathology oncology research, 2019-10, Vol.25 (4), p.1579-1587
issn 1219-4956
1532-2807
language eng
recordid cdi_proquest_journals_2308968268
source MEDLINE; SpringerNature Journals
subjects Amines
Biomarkers, Tumor - genetics
Biomedical and Life Sciences
Biomedicine
Cancer Research
Carcinogenesis
Case-Control Studies
Clonal deletion
Colorectal cancer
Colorectal carcinoma
Colorectal Neoplasms - genetics
Colorectal Neoplasms - pathology
Detoxification
Enzymatic activity
Female
Follow-Up Studies
Gene deletion
Gene polymorphism
Genetic Predisposition to Disease
Genotype
Genotype & phenotype
Genotypes
Glutathione
Glutathione S-Transferase pi - genetics
Glutathione transferase
Glutathione Transferase - genetics
GSTM1 protein
GSTT1 protein
Health risks
Humans
Immunology
Male
Middle Aged
Oncology
Original Article
Pathology
Polycyclic aromatic hydrocarbons
Polymerase chain reaction
Polymorphism
Polymorphism, Single Nucleotide
Prognosis
Restriction fragment length polymorphism
Risk Factors
Sequence Deletion
Single-nucleotide polymorphism
Statistical analysis
title Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T11%3A06%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deletion%20and%20Single%20Nucleotide%20Polymorphisms%20in%20Common%20Glutathione-S%20Transferases%20Contribute%20to%20Colorectal%20Cancer%20Development&rft.jtitle=Pathology%20oncology%20research&rft.au=Stojkovic%20Lalosevic,%20Milica%20Lj&rft.date=2019-10-01&rft.volume=25&rft.issue=4&rft.spage=1579&rft.epage=1587&rft.pages=1579-1587&rft.issn=1219-4956&rft.eissn=1532-2807&rft_id=info:doi/10.1007/s12253-019-00589-1&rft_dat=%3Cproquest_cross%3E2172483765%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2172483765&rft_id=info:pmid/30694518&rfr_iscdi=true